Publication | Open Access
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab
33
Citations
29
References
2024
Year
Although talquetamab had a distinct safety profile, AEs were considered clinically manageable and mostly low grade. With appropriate education and support, health care practitioners can ensure patients with RRMM maintain quality of life and treatment adherence. VIDEO ABSTRACT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1